Cargando…

A rare pituitary tumor associated with hyperthyroidism and acromegaly

BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Meng, Liheng, Liu, Yuping, Tamrakar, Rashi, Yang, Xi, Liang, Xinghuang, Zhou, Jia, Xian, Jing, Huang, Zhenxing, Qin, Yingfen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816123/
https://www.ncbi.nlm.nih.gov/pubmed/36619586
http://dx.doi.org/10.3389/fendo.2022.1072647
_version_ 1784864460370870272
author Li, Li
Meng, Liheng
Liu, Yuping
Tamrakar, Rashi
Yang, Xi
Liang, Xinghuang
Zhou, Jia
Xian, Jing
Huang, Zhenxing
Qin, Yingfen
author_facet Li, Li
Meng, Liheng
Liu, Yuping
Tamrakar, Rashi
Yang, Xi
Liang, Xinghuang
Zhou, Jia
Xian, Jing
Huang, Zhenxing
Qin, Yingfen
author_sort Li, Li
collection PubMed
description BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed with pituitary adenoma based on various symptoms and clinical findings. For further examination and treatment, he was hospitalized in our institution. It was likely that this subject had pituitary adenoma producing both GH and TSH. In brain magnetic resonance imaging, there was a giant tumor in the sellar region. After the diagnosis of mixed pituitary TSH/GH adenoma, he was treated with octreotide, then underwent tumor resection, and then received hydrocortisone acetate and levothyroxine sodium. After then, GH and IGF-1 levels were suppressed and thyroid function was normalized. Postoperative immunohistochemistry reports showed GH (+) but TSH (-), which may be insensitive to the antibody used to detect TSH or combined with other factors. CONCLUSIONS: The diagnosis of mixed pituitary TSH/GH adenoma must be combined with clinical manifestations, immunohistochemical staining and relevant hormone levels, and genetic testing if necessary for comprehensive judgment. For patients with large adenomas, it is recommended to use somatostatin analogs to restore TH levels and control the excessive secretion of GH levels before surgery.
format Online
Article
Text
id pubmed-9816123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98161232023-01-07 A rare pituitary tumor associated with hyperthyroidism and acromegaly Li, Li Meng, Liheng Liu, Yuping Tamrakar, Rashi Yang, Xi Liang, Xinghuang Zhou, Jia Xian, Jing Huang, Zhenxing Qin, Yingfen Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed with pituitary adenoma based on various symptoms and clinical findings. For further examination and treatment, he was hospitalized in our institution. It was likely that this subject had pituitary adenoma producing both GH and TSH. In brain magnetic resonance imaging, there was a giant tumor in the sellar region. After the diagnosis of mixed pituitary TSH/GH adenoma, he was treated with octreotide, then underwent tumor resection, and then received hydrocortisone acetate and levothyroxine sodium. After then, GH and IGF-1 levels were suppressed and thyroid function was normalized. Postoperative immunohistochemistry reports showed GH (+) but TSH (-), which may be insensitive to the antibody used to detect TSH or combined with other factors. CONCLUSIONS: The diagnosis of mixed pituitary TSH/GH adenoma must be combined with clinical manifestations, immunohistochemical staining and relevant hormone levels, and genetic testing if necessary for comprehensive judgment. For patients with large adenomas, it is recommended to use somatostatin analogs to restore TH levels and control the excessive secretion of GH levels before surgery. Frontiers Media S.A. 2022-12-23 /pmc/articles/PMC9816123/ /pubmed/36619586 http://dx.doi.org/10.3389/fendo.2022.1072647 Text en Copyright © 2022 Li, Meng, Liu, Tamrakar, Yang, Liang, Zhou, Xian, Huang and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Li, Li
Meng, Liheng
Liu, Yuping
Tamrakar, Rashi
Yang, Xi
Liang, Xinghuang
Zhou, Jia
Xian, Jing
Huang, Zhenxing
Qin, Yingfen
A rare pituitary tumor associated with hyperthyroidism and acromegaly
title A rare pituitary tumor associated with hyperthyroidism and acromegaly
title_full A rare pituitary tumor associated with hyperthyroidism and acromegaly
title_fullStr A rare pituitary tumor associated with hyperthyroidism and acromegaly
title_full_unstemmed A rare pituitary tumor associated with hyperthyroidism and acromegaly
title_short A rare pituitary tumor associated with hyperthyroidism and acromegaly
title_sort rare pituitary tumor associated with hyperthyroidism and acromegaly
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816123/
https://www.ncbi.nlm.nih.gov/pubmed/36619586
http://dx.doi.org/10.3389/fendo.2022.1072647
work_keys_str_mv AT lili ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT mengliheng ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT liuyuping ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT tamrakarrashi ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT yangxi ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT liangxinghuang ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT zhoujia ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT xianjing ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT huangzhenxing ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT qinyingfen ararepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT lili rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT mengliheng rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT liuyuping rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT tamrakarrashi rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT yangxi rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT liangxinghuang rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT zhoujia rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT xianjing rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT huangzhenxing rarepituitarytumorassociatedwithhyperthyroidismandacromegaly
AT qinyingfen rarepituitarytumorassociatedwithhyperthyroidismandacromegaly